Orient Europharma Co

Orient Europharma Co EBIT Margin

The EBIT Margin (Operating Margin) of Orient Europharma Co (4120.TWO) as of Oct 17, 2026 is -6.50 %. In the previous year, EBIT Margin (Operating Margin) was 0.30 % — a change of -2,243.10% (lower).

EBIT Margin

-6.50 %

YoY

-2,243.10%

Last updated:

EBIT Margin (Operating Margin) of Orient Europharma Co is 2025 -6.50 % . EBIT Margin (Operating Margin) of Orient Europharma Co was 2024 0.30 % . It decreases by -2,243.10% lower compared to the previous year.

For Orient Europharma Co, the operating (EBIT) margin of -6.5% is down versus 2.3% a few years ago.

The Orient Europharma Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
6.48 TWD
Jan 1, 2019
5.52 TWD
Jan 1, 2020
2.18 TWD
Jan 1, 2021
2.33 TWD
Jan 1, 2022
-5.91 TWD
Jan 1, 2023
1.57 TWD
Jan 1, 2024
0.30 TWD
Jan 1, 2025
-6.50 TWD
The Orient Europharma Co EBIT Margin history
YEAREBIT MarginYoY
-6.50 %-2,243.10%
0.30 %-80.69%
1.57 %-126.58%
-5.91 %-353.92%
2.33 %+6.77%
2.18 %-60.52%
5.52 %-14.83%
6.48 %-22.19%
8.33 %-3.32%
8.62 %+60.45%
5.37 %+25.81%
4.27 %+30,129.40%
0.01 %-65.56%
0.04 %-7.31%
0.04 %-43.31%
0.08 %-23.86%
0.10 %+11.71%
0.09 %+12.98%
0.08 %-2.15%
0.08 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Orient Europharma Co Stock analysis

What does Orient Europharma Co do? Orient Europharma Co Ltd, based in Taipei City, Taiwan, operates in the Health Care sector, specifically within Pharmaceuticals. The company manufactures and trades western medicine, health food, and cosmetics, with a focus on nutritious healthcare products, medical cosmetic products, and western drugs. Its product segments include infant milk powders, functional healthcare items, dermatological preparations, medical hair care, organic skincare, and pharmaceuticals for conditions such as cardiovascular diseases, cancer, and diabetes. Listed on 28 November 2002. Orient Europharma Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orient Europharma Co stock

EBIT Margin (Operating Margin) of Orient Europharma Co is -6.50 % in 2025.

EBIT Margin (Operating Margin) of Orient Europharma Co changed from 0.30 % to -6.50 %, representing a -2,243.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Orient Europharma Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Orient Europharma Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Orient Europharma Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Orient Europharma Co